BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 23280926)

  • 21. Discovery of new inhibitors of Mycobacterium tuberculosis InhA enzyme using virtual screening and a 3D-pharmacophore-based approach.
    Pauli I; dos Santos RN; Rostirolla DC; Martinelli LK; Ducati RG; Timmers LF; Basso LA; Santos DS; Guido RV; Andricopulo AD; Norberto de Souza O
    J Chem Inf Model; 2013 Sep; 53(9):2390-401. PubMed ID: 23889525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In silico study directed towards identification of the key structural features of GyrB inhibitors targeting MTB DNA gyrase: HQSAR, CoMSIA and molecular dynamics simulations.
    Kamsri P; Punkvang A; Hannongbua S; Suttisintong K; Kittakoop P; Spencer J; Mulholland AJ; Pungpo P
    SAR QSAR Environ Res; 2019 Nov; 30(11):775-800. PubMed ID: 31607177
    [No Abstract]   [Full Text] [Related]  

  • 23. Cross-docking study on InhA inhibitors: a combination of Autodock Vina and PM6-DH2 simulations to retrieve bio-active conformations.
    Stigliani JL; Bernardes-Génisson V; Bernadou J; Pratviel G
    Org Biomol Chem; 2012 Aug; 10(31):6341-9. PubMed ID: 22751934
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of Potent DNA Gyrase Inhibitors Active against
    Pakamwong B; Thongdee P; Kamsri B; Phusi N; Kamsri P; Punkvang A; Ketrat S; Saparpakorn P; Hannongbua S; Ariyachaokun K; Suttisintong K; Sureram S; Kittakoop P; Hongmanee P; Santanirand P; Spencer J; Mulholland AJ; Pungpo P
    J Chem Inf Model; 2022 Apr; 62(7):1680-1690. PubMed ID: 35347987
    [No Abstract]   [Full Text] [Related]  

  • 25. Synthesis of gatifloxacin derivatives and their biological activities against Mycobacterium leprae and Mycobacterium tuberculosis.
    Gomez C; Ponien P; Serradji N; Lamouri A; Pantel A; Capton E; Jarlier V; Anquetin G; Aubry A
    Bioorg Med Chem; 2013 Feb; 21(4):948-56. PubMed ID: 23294829
    [TBL] [Abstract][Full Text] [Related]  

  • 26. De novo design of novel DNA-gyrase inhibitors based on 2D molecular fingerprints.
    Huang Z; Lin K; You Q
    Bioorg Med Chem Lett; 2013 Jul; 23(14):4166-71. PubMed ID: 23743285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of ssDNA aptamers as potent inhibitors of Mycobacterium tuberculosis acetohydroxyacid synthase.
    Baig IA; Moon JY; Lee SC; Ryoo SW; Yoon MY
    Biochim Biophys Acta; 2015 Oct; 1854(10 Pt A):1338-50. PubMed ID: 25988243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting essential cell wall lipase Rv3802c for potential therapeutics against tuberculosis.
    Saravanan P; Avinash H; Dubey VK; Patra S
    J Mol Graph Model; 2012 Sep; 38():235-42. PubMed ID: 23085165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In silico assessment of adverse effects of a large set of 6-fluoroquinolones obtained from a study of tuberculosis chemotherapy.
    Tusar M; Minovski N; Fjodorova N; Novic M
    Curr Drug Saf; 2012 Sep; 7(4):313-20. PubMed ID: 23062244
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional analysis of DNA gyrase mutant enzymes carrying mutations at position 88 in the A subunit found in clinical strains of Mycobacterium tuberculosis resistant to fluoroquinolones.
    Matrat S; Veziris N; Mayer C; Jarlier V; Truffot-Pernot C; Camuset J; Bouvet E; Cambau E; Aubry A
    Antimicrob Agents Chemother; 2006 Dec; 50(12):4170-3. PubMed ID: 17015625
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Shape-based virtual screening, docking, and molecular dynamics simulations to identify Mtb-ASADH inhibitors.
    Kumar R; Garg P; Bharatam PV
    J Biomol Struct Dyn; 2015; 33(5):1082-93. PubMed ID: 24875451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery of novel inhibitors of Mycobacterium tuberculosis MurG: homology modelling, structure based pharmacophore, molecular docking, and molecular dynamics simulations.
    Saxena S; Abdullah M; Sriram D; Guruprasad L
    J Biomol Struct Dyn; 2018 Sep; 36(12):3184-3198. PubMed ID: 28948866
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure-based in silico design of a high-affinity dipeptide inhibitor for novel protein drug target Shikimate kinase of Mycobacterium tuberculosis.
    Kumar M; Verma S; Sharma S; Srinivasan A; Singh TP; Kaur P
    Chem Biol Drug Des; 2010 Sep; 76(3):277-84. PubMed ID: 20626408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure-based design of a potent and selective small peptide inhibitor of Mycobacterium tuberculosis 6-hydroxymethyl-7, 8-dihydropteroate synthase: a computer modelling approach.
    Rao GS; Kumar M
    Chem Biol Drug Des; 2008 Jun; 71(6):540-5. PubMed ID: 18482337
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanism of binding of fluoroquinolones to the quinolone resistance-determining region of DNA gyrase: towards an understanding of the molecular basis of quinolone resistance.
    Madurga S; Sánchez-Céspedes J; Belda I; Vila J; Giralt E
    Chembiochem; 2008 Sep; 9(13):2081-6. PubMed ID: 18677735
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New Chromane-Based Derivatives as Inhibitors of
    Pini E; Poli G; Tuccinardi T; Chiarelli LR; Mori M; Gelain A; Costantino L; Villa S; Meneghetti F; Barlocco D
    Molecules; 2018 Jun; 23(7):. PubMed ID: 29933627
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combinatorially-generated library of 6-fluoroquinolone analogs as potential novel antitubercular agents: a chemometric and molecular modeling assessment.
    Minovski N; Perdih A; Solmajer T
    J Mol Model; 2012 May; 18(5):1735-53. PubMed ID: 21833830
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Probing the structure of Mycobacterium tuberculosis MbtA: model validation using molecular dynamics simulations and docking studies.
    Maganti L; Open Source Drug Discovery Consortium ; Ghoshal N
    J Biomol Struct Dyn; 2014; 32(2):273-88. PubMed ID: 23527569
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Integration of ligand and structure based approaches for identification of novel MbtI inhibitors in Mycobacterium tuberculosis and molecular dynamics simulation studies.
    Maganti L; Grandhi P; Ghoshal N
    J Mol Graph Model; 2016 Nov; 70():14-22. PubMed ID: 27639087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural insight into Mycobacterium tuberculosis maltosyl transferase inhibitors: pharmacophore-based virtual screening, docking, and molecular dynamics simulations.
    Sengupta S; Roy D; Bandyopadhyay S
    J Biomol Struct Dyn; 2015; 33(12):2655-66. PubMed ID: 25669125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.